The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance Article Swipe
Victor‐Emmanuel Brett
,
Nicolas Lechevalier
,
Franck Trimoreau
,
Charles Dussiau
,
Sophie Dimicoli‐Salazar
,
Lucie Coster
,
Isabelle Luquet
,
Nathalie Nadal
,
Bénédicte Ribourtout
,
Élise Chapiro
,
Christine Lefebvre
,
Sylvie Tondeur
,
Estelle Balducci
,
Florence Nguyen‐Khac
,
Claire Borie
,
Isabelle Radford‐Weiss
,
Carole Barin
,
Virginie Éclache
,
Olivier Mansier
,
Audrey Bidet
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/gcc.23107
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/gcc.23107
Myelodysplastic syndromes (MDS) are hematological malignancies classically defined by the presence of cytopenia(s) and dysmorphic myeloid cells. It is now known that MDS can be preceded by a pre‐malignant condition called clonal cytopenia of unknown significance (CCUS), which associates a clonality marker with cytopenia in the absence of criteria of dysplasia. However, to date, it is not clear whether chromosomal abnormalities should be considered in the definition of CCUS or if they carry a prognostic impact in CCUS patients. In this study, we analyzed the clinico‐biological features and outcomes of 34 patients who presented with one or more cytopenias, an absence of significant dysplasia, and a presence of a chromosomal abnormality (CA). We named this entity chromosomal abnormality with cytopenia of undetermined significance (CACtUS). We show that these patients are slightly older than MDS patients and that they more frequently presented with normocytic anemia. Most CACtUS patients exhibited only one unbalanced CA. The number and type of mutations were comparable between CACtUS patients and MDS patients. Regardless of the cytogenetic abnormality, the clinicobiological characteristics, overall survival, and risk of progression to high‐risk (HR) MDS were similar between CACtUS patients and low‐risk MDS patients. Thus, we suggest that CACtUS patients can be considered as HR‐CCUS and should receive the follow‐up regimen recommended for MDS patients.
Related Topics
Concepts
Cytopenia
Abnormality
Myelodysplastic syndromes
Dysplasia
Medicine
Chromosome abnormality
Internal medicine
Clinical significance
Karyotype
Genetics
Biology
Chromosome
Bone marrow
Gene
Psychiatry
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/gcc.23107
- OA Status
- green
- Cited By
- 8
- References
- 36
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4309575922
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4309575922Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/gcc.23107Digital Object Identifier
- Title
-
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significanceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-11-22Full publication date if available
- Authors
-
Victor‐Emmanuel Brett, Nicolas Lechevalier, Franck Trimoreau, Charles Dussiau, Sophie Dimicoli‐Salazar, Lucie Coster, Isabelle Luquet, Nathalie Nadal, Bénédicte Ribourtout, Élise Chapiro, Christine Lefebvre, Sylvie Tondeur, Estelle Balducci, Florence Nguyen‐Khac, Claire Borie, Isabelle Radford‐Weiss, Carole Barin, Virginie Éclache, Olivier Mansier, Audrey BidetList of authors in order
- Landing page
-
https://doi.org/10.1002/gcc.23107Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://hal.science/hal-04022577Direct OA link when available
- Concepts
-
Cytopenia, Abnormality, Myelodysplastic syndromes, Dysplasia, Medicine, Chromosome abnormality, Internal medicine, Clinical significance, Karyotype, Genetics, Biology, Chromosome, Bone marrow, Gene, PsychiatryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
8Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 2, 2023: 5Per-year citation counts (last 5 years)
- References (count)
-
36Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4309575922 |
|---|---|
| doi | https://doi.org/10.1002/gcc.23107 |
| ids.doi | https://doi.org/10.1002/gcc.23107 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36412977 |
| ids.openalex | https://openalex.org/W4309575922 |
| fwci | 1.79639306 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D002869 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Chromosome Aberrations |
| mesh[2].qualifier_ui | Q000235 |
| mesh[2].descriptor_ui | D009190 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | genetics |
| mesh[2].descriptor_name | Myelodysplastic Syndromes |
| mesh[3].qualifier_ui | Q000473 |
| mesh[3].descriptor_ui | D009190 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pathology |
| mesh[3].descriptor_name | Myelodysplastic Syndromes |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D009154 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Mutation |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D019337 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Hematologic Neoplasms |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D025063 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Chromosome Disorders |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000740 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Anemia |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D002869 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Chromosome Aberrations |
| mesh[10].qualifier_ui | Q000235 |
| mesh[10].descriptor_ui | D009190 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | genetics |
| mesh[10].descriptor_name | Myelodysplastic Syndromes |
| mesh[11].qualifier_ui | Q000473 |
| mesh[11].descriptor_ui | D009190 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | pathology |
| mesh[11].descriptor_name | Myelodysplastic Syndromes |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D009154 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Mutation |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D019337 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Hematologic Neoplasms |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D025063 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Chromosome Disorders |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000740 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Anemia |
| type | article |
| title | The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance |
| biblio.issue | 3 |
| biblio.volume | 62 |
| biblio.last_page | 151 |
| biblio.first_page | 139 |
| topics[0].id | https://openalex.org/T10309 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Acute Myeloid Leukemia Research |
| topics[1].id | https://openalex.org/T12919 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Blood disorders and treatments |
| topics[2].id | https://openalex.org/T10185 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9976000189781189 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2734 |
| topics[2].subfield.display_name | Pathology and Forensic Medicine |
| topics[2].display_name | Lymphoma Diagnosis and Treatment |
| is_xpac | False |
| apc_list.value | 4840 |
| apc_list.currency | USD |
| apc_list.value_usd | 4840 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780366003 |
| concepts[0].level | 3 |
| concepts[0].score | 0.971116840839386 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q246147 |
| concepts[0].display_name | Cytopenia |
| concepts[1].id | https://openalex.org/C50965678 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7319484949111938 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2724302 |
| concepts[1].display_name | Abnormality |
| concepts[2].id | https://openalex.org/C2780817109 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6838220953941345 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q954625 |
| concepts[2].display_name | Myelodysplastic syndromes |
| concepts[3].id | https://openalex.org/C2775894508 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6235458850860596 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1128996 |
| concepts[3].display_name | Dysplasia |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5209356546401978 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C2780189214 |
| concepts[5].level | 5 |
| concepts[5].score | 0.5175351500511169 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q744962 |
| concepts[5].display_name | Chromosome abnormality |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5006866455078125 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C63363279 |
| concepts[7].level | 2 |
| concepts[7].score | 0.45488691329956055 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q5133848 |
| concepts[7].display_name | Clinical significance |
| concepts[8].id | https://openalex.org/C53226629 |
| concepts[8].level | 4 |
| concepts[8].score | 0.3323800563812256 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q189967 |
| concepts[8].display_name | Karyotype |
| concepts[9].id | https://openalex.org/C54355233 |
| concepts[9].level | 1 |
| concepts[9].score | 0.26847946643829346 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[9].display_name | Genetics |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.23250752687454224 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C30481170 |
| concepts[11].level | 3 |
| concepts[11].score | 0.20089703798294067 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q37748 |
| concepts[11].display_name | Chromosome |
| concepts[12].id | https://openalex.org/C2780007613 |
| concepts[12].level | 2 |
| concepts[12].score | 0.1871342658996582 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q546523 |
| concepts[12].display_name | Bone marrow |
| concepts[13].id | https://openalex.org/C104317684 |
| concepts[13].level | 2 |
| concepts[13].score | 0.057038962841033936 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[13].display_name | Gene |
| concepts[14].id | https://openalex.org/C118552586 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[14].display_name | Psychiatry |
| keywords[0].id | https://openalex.org/keywords/cytopenia |
| keywords[0].score | 0.971116840839386 |
| keywords[0].display_name | Cytopenia |
| keywords[1].id | https://openalex.org/keywords/abnormality |
| keywords[1].score | 0.7319484949111938 |
| keywords[1].display_name | Abnormality |
| keywords[2].id | https://openalex.org/keywords/myelodysplastic-syndromes |
| keywords[2].score | 0.6838220953941345 |
| keywords[2].display_name | Myelodysplastic syndromes |
| keywords[3].id | https://openalex.org/keywords/dysplasia |
| keywords[3].score | 0.6235458850860596 |
| keywords[3].display_name | Dysplasia |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.5209356546401978 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/chromosome-abnormality |
| keywords[5].score | 0.5175351500511169 |
| keywords[5].display_name | Chromosome abnormality |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5006866455078125 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/clinical-significance |
| keywords[7].score | 0.45488691329956055 |
| keywords[7].display_name | Clinical significance |
| keywords[8].id | https://openalex.org/keywords/karyotype |
| keywords[8].score | 0.3323800563812256 |
| keywords[8].display_name | Karyotype |
| keywords[9].id | https://openalex.org/keywords/genetics |
| keywords[9].score | 0.26847946643829346 |
| keywords[9].display_name | Genetics |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.23250752687454224 |
| keywords[10].display_name | Biology |
| keywords[11].id | https://openalex.org/keywords/chromosome |
| keywords[11].score | 0.20089703798294067 |
| keywords[11].display_name | Chromosome |
| keywords[12].id | https://openalex.org/keywords/bone-marrow |
| keywords[12].score | 0.1871342658996582 |
| keywords[12].display_name | Bone marrow |
| keywords[13].id | https://openalex.org/keywords/gene |
| keywords[13].score | 0.057038962841033936 |
| keywords[13].display_name | Gene |
| language | en |
| locations[0].id | doi:10.1002/gcc.23107 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S200862508 |
| locations[0].source.issn | 1045-2257, 1098-2264 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1045-2257 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Genes Chromosomes and Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Genes, Chromosomes and Cancer |
| locations[0].landing_page_url | https://doi.org/10.1002/gcc.23107 |
| locations[1].id | pmid:36412977 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Genes, chromosomes & cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36412977 |
| locations[2].id | pmh:oai:HAL:hal-04022577v1 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal articles |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Genes, Chromosomes & Cancer, 2023, 62 (3), pp.139-151. ⟨10.1002/gcc.23107⟩ |
| locations[2].landing_page_url | https://hal.science/hal-04022577 |
| locations[3].id | pmh:oai:oskar-bordeaux.fr:20.500.12278/172242 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306402569 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Oskar-Bordeaux (Universite de Bordeaux) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Article de revue |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://oskar-bordeaux.fr/handle/20.500.12278/172242 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5003443627 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9811-5003 |
| authorships[0].author.display_name | Victor‐Emmanuel Brett |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I3018323443 |
| authorships[0].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[0].institutions[0].id | https://openalex.org/I3018323443 |
| authorships[0].institutions[0].ror | https://ror.org/01hq89f96 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I3018323443 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Victor‐Emmanuel Brett |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[1].author.id | https://openalex.org/A5050978810 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-1959-7938 |
| authorships[1].author.display_name | Nicolas Lechevalier |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I3018323443 |
| authorships[1].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[1].institutions[0].id | https://openalex.org/I3018323443 |
| authorships[1].institutions[0].ror | https://ror.org/01hq89f96 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I3018323443 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nicolas Lechevalier |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[2].author.id | https://openalex.org/A5001869180 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Franck Trimoreau |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210118469 |
| authorships[2].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Limoges Limoges France |
| authorships[2].institutions[0].id | https://openalex.org/I4210118469 |
| authorships[2].institutions[0].ror | https://ror.org/01tc2d264 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210118469 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Centre Hospitalier Universitaire de Limoges |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Franck Trimoreau |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Laboratoire d'Hématologie Biologique CHU Limoges Limoges France |
| authorships[3].author.id | https://openalex.org/A5084488460 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0646-0617 |
| authorships[3].author.display_name | Charles Dussiau |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I3018323443 |
| authorships[3].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I4387154723 |
| authorships[3].affiliations[1].raw_affiliation_string | INSERM U1034, Biology of cardiovascular disease Pessac France |
| authorships[3].institutions[0].id | https://openalex.org/I4387154723 |
| authorships[3].institutions[0].ror | https://ror.org/0463z7496 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I15057530, https://openalex.org/I154526488, https://openalex.org/I4387154723 |
| authorships[3].institutions[0].country_code | |
| authorships[3].institutions[0].display_name | Biologie des maladies cardiovasculaires |
| authorships[3].institutions[1].id | https://openalex.org/I3018323443 |
| authorships[3].institutions[1].ror | https://ror.org/01hq89f96 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I3018323443 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[3].institutions[2].id | https://openalex.org/I154526488 |
| authorships[3].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[3].institutions[2].type | government |
| authorships[3].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[3].institutions[2].country_code | FR |
| authorships[3].institutions[2].display_name | Inserm |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Charles Dussiau |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | INSERM U1034, Biology of cardiovascular disease Pessac France, Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[4].author.id | https://openalex.org/A5018060677 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Sophie Dimicoli‐Salazar |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I3018323443 |
| authorships[4].affiliations[0].raw_affiliation_string | Service d'hématologie clinique CHU Bordeaux Bordeaux |
| authorships[4].institutions[0].id | https://openalex.org/I3018323443 |
| authorships[4].institutions[0].ror | https://ror.org/01hq89f96 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I3018323443 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sophie Dimicoli‐Salazar |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Service d'hématologie clinique CHU Bordeaux Bordeaux |
| authorships[5].author.id | https://openalex.org/A5012769406 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7993-7485 |
| authorships[5].author.display_name | Lucie Coster |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie CHU Toulouse, site IUCT‐O Toulouse France |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[5].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[5].institutions[0].id | https://openalex.org/I4210138283 |
| authorships[5].institutions[0].ror | https://ror.org/04db0ec72 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210138283 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Groupe Francophone des Myélodysplasies |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lucie Coster |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie CHU Toulouse, site IUCT‐O Toulouse France |
| authorships[6].author.id | https://openalex.org/A5011158086 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Isabelle Luquet |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[6].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[6].affiliations[1].raw_affiliation_string | Laboratoire d'Hématologie CHU Toulouse, site IUCT‐O Toulouse France |
| authorships[6].institutions[0].id | https://openalex.org/I4210138283 |
| authorships[6].institutions[0].ror | https://ror.org/04db0ec72 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210138283 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Groupe Francophone des Myélodysplasies |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Isabelle Luquet |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie CHU Toulouse, site IUCT‐O Toulouse France |
| authorships[7].author.id | https://openalex.org/A5064614311 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8424-5141 |
| authorships[7].author.display_name | Nathalie Nadal |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[7].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I4210116240 |
| authorships[7].affiliations[1].raw_affiliation_string | Service de génétique chromosomique et moléculaire CHU Dijon Dijon France |
| authorships[7].institutions[0].id | https://openalex.org/I4210116240 |
| authorships[7].institutions[0].ror | https://ror.org/0377z4z10 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210116240 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | CHU Dijon Bourgogne |
| authorships[7].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[7].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[7].institutions[1].type | nonprofit |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Nathalie Nadal |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Service de génétique chromosomique et moléculaire CHU Dijon Dijon France |
| authorships[8].author.id | https://openalex.org/A5070266462 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Bénédicte Ribourtout |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210112910 |
| authorships[8].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie CHU Angers Angers France |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[8].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[8].institutions[0].id | https://openalex.org/I4210112910 |
| authorships[8].institutions[0].ror | https://ror.org/0250ngj72 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210112910 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Centre Hospitalier Universitaire d'Angers |
| authorships[8].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[8].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[8].institutions[1].type | nonprofit |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Bénédicte Ribourtout |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie CHU Angers Angers France |
| authorships[9].author.id | https://openalex.org/A5009805216 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3427-7596 |
| authorships[9].author.display_name | Élise Chapiro |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I39804081, https://openalex.org/I4210121705 |
| authorships[9].affiliations[0].raw_affiliation_string | Service d'Hématologie Biologique Hôpital Pitié‐Salpêtrière, AP‐HP Paris France |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[9].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210092322 |
| authorships[9].affiliations[2].raw_affiliation_string | Cell Death and Drug Resistance in Lymphoproliferative Disorders Team Centre de Recherche des Cordeliers, INSERM UMRS 1138; Sorbonne Université Paris France |
| authorships[9].institutions[0].id | https://openalex.org/I4210092322 |
| authorships[9].institutions[0].ror | https://ror.org/00dmms154 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I39804081, https://openalex.org/I4210092322 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Centre de Recherche des Cordeliers |
| authorships[9].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[9].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[9].institutions[1].type | nonprofit |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[9].institutions[2].id | https://openalex.org/I154526488 |
| authorships[9].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[9].institutions[2].type | government |
| authorships[9].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[9].institutions[2].country_code | FR |
| authorships[9].institutions[2].display_name | Inserm |
| authorships[9].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[9].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[9].institutions[3].type | healthcare |
| authorships[9].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[9].institutions[3].country_code | FR |
| authorships[9].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[9].institutions[4].id | https://openalex.org/I39804081 |
| authorships[9].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[9].institutions[4].type | education |
| authorships[9].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[9].institutions[4].country_code | FR |
| authorships[9].institutions[4].display_name | Sorbonne Université |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Elise Chapiro |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Cell Death and Drug Resistance in Lymphoproliferative Disorders Team Centre de Recherche des Cordeliers, INSERM UMRS 1138; Sorbonne Université Paris France, Groupe Francophone de Cytogénétique Hématologique (GFCH), Service d'Hématologie Biologique Hôpital Pitié‐Salpêtrière, AP‐HP Paris France |
| authorships[10].author.id | https://openalex.org/A5041657079 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0424-3731 |
| authorships[10].author.display_name | Christine Lefebvre |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[10].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I2800555055 |
| authorships[10].affiliations[1].raw_affiliation_string | Laboratoire de Cytogénétique des Hémopathies CHU Grenoble Alpes Grenoble France |
| authorships[10].institutions[0].id | https://openalex.org/I2800555055 |
| authorships[10].institutions[0].ror | https://ror.org/041rhpw39 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2800555055 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Centre Hospitalier Universitaire de Grenoble |
| authorships[10].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[10].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[10].institutions[1].type | nonprofit |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Christine Lefebvre |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire de Cytogénétique des Hémopathies CHU Grenoble Alpes Grenoble France |
| authorships[11].author.id | https://openalex.org/A5109919169 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Sylvie Tondeur |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210157006 |
| authorships[11].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie CHU St‐Etienne St Etienne France |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[11].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[11].institutions[0].id | https://openalex.org/I4210157006 |
| authorships[11].institutions[0].ror | https://ror.org/04pn6vp43 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210157006 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Centre Hospitalier Universitaire de Saint-Étienne |
| authorships[11].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[11].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[11].institutions[1].type | nonprofit |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Sylvie Tondeur |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie CHU St‐Etienne St Etienne France |
| authorships[12].author.id | https://openalex.org/A5059743121 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-6792-1291 |
| authorships[12].author.display_name | Estelle Balducci |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[12].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210164847 |
| authorships[12].affiliations[1].raw_affiliation_string | Laboratoire d'Hématologie Hôpital Paul Brousse, APHP Paris France |
| authorships[12].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[12].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[12].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[12].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[12].institutions[1].type | nonprofit |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[12].institutions[1].country_code | FR |
| authorships[12].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[12].institutions[2].id | https://openalex.org/I4210164847 |
| authorships[12].institutions[2].ror | https://ror.org/05n7yzd13 |
| authorships[12].institutions[2].type | healthcare |
| authorships[12].institutions[2].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210164847, https://openalex.org/I4413047524 |
| authorships[12].institutions[2].country_code | FR |
| authorships[12].institutions[2].display_name | Hôpital Paul-Brousse |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Estelle Balducci |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie Hôpital Paul Brousse, APHP Paris France |
| authorships[13].author.id | https://openalex.org/A5015238852 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-3107-6668 |
| authorships[13].author.display_name | Florence Nguyen‐Khac |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210092322 |
| authorships[13].affiliations[0].raw_affiliation_string | Cell Death and Drug Resistance in Lymphoproliferative Disorders Team Centre de Recherche des Cordeliers, INSERM UMRS 1138; Sorbonne Université Paris France |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[13].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[13].affiliations[2].institution_ids | https://openalex.org/I39804081, https://openalex.org/I4210121705 |
| authorships[13].affiliations[2].raw_affiliation_string | Service d'Hématologie Biologique Hôpital Pitié‐Salpêtrière, AP‐HP Paris France |
| authorships[13].institutions[0].id | https://openalex.org/I4210092322 |
| authorships[13].institutions[0].ror | https://ror.org/00dmms154 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I39804081, https://openalex.org/I4210092322 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Centre de Recherche des Cordeliers |
| authorships[13].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[13].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[13].institutions[1].type | nonprofit |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[13].institutions[1].country_code | FR |
| authorships[13].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[13].institutions[2].id | https://openalex.org/I154526488 |
| authorships[13].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[13].institutions[2].type | government |
| authorships[13].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[13].institutions[2].country_code | FR |
| authorships[13].institutions[2].display_name | Inserm |
| authorships[13].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[13].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[13].institutions[3].type | healthcare |
| authorships[13].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[13].institutions[3].country_code | FR |
| authorships[13].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[13].institutions[4].id | https://openalex.org/I39804081 |
| authorships[13].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[13].institutions[4].type | education |
| authorships[13].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[13].institutions[4].country_code | FR |
| authorships[13].institutions[4].display_name | Sorbonne Université |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Florence Nguyen‐Khac |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Cell Death and Drug Resistance in Lymphoproliferative Disorders Team Centre de Recherche des Cordeliers, INSERM UMRS 1138; Sorbonne Université Paris France, Groupe Francophone de Cytogénétique Hématologique (GFCH), Service d'Hématologie Biologique Hôpital Pitié‐Salpêtrière, AP‐HP Paris France |
| authorships[14].author.id | https://openalex.org/A5028898520 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Claire Borie |
| authorships[14].countries | FR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210164847 |
| authorships[14].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Hôpital Paul Brousse, APHP Paris France |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[14].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[14].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].country_code | FR |
| authorships[14].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[14].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[14].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[14].institutions[1].type | nonprofit |
| authorships[14].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[14].institutions[1].country_code | FR |
| authorships[14].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[14].institutions[2].id | https://openalex.org/I4210164847 |
| authorships[14].institutions[2].ror | https://ror.org/05n7yzd13 |
| authorships[14].institutions[2].type | healthcare |
| authorships[14].institutions[2].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210164847, https://openalex.org/I4413047524 |
| authorships[14].institutions[2].country_code | FR |
| authorships[14].institutions[2].display_name | Hôpital Paul-Brousse |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Claire Borie |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie Hôpital Paul Brousse, APHP Paris France |
| authorships[15].author.id | https://openalex.org/A5109234557 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Isabelle Radford‐Weiss |
| authorships[15].countries | FR |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[15].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I1288880153, https://openalex.org/I4210097159 |
| authorships[15].affiliations[1].raw_affiliation_string | Laboratoire de Cytogénétique Hôpital Necker—Enfants Malades, APHP Paris France |
| authorships[15].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[15].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[15].institutions[0].country_code | FR |
| authorships[15].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[15].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[15].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[15].institutions[1].type | nonprofit |
| authorships[15].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[15].institutions[1].country_code | FR |
| authorships[15].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[15].institutions[2].id | https://openalex.org/I1288880153 |
| authorships[15].institutions[2].ror | https://ror.org/05tr67282 |
| authorships[15].institutions[2].type | healthcare |
| authorships[15].institutions[2].lineage | https://openalex.org/I1288880153, https://openalex.org/I4210097159, https://openalex.org/I4210120235 |
| authorships[15].institutions[2].country_code | FR |
| authorships[15].institutions[2].display_name | Hôpital Necker-Enfants Malades |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Isabelle Radford‐Weiss |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire de Cytogénétique Hôpital Necker—Enfants Malades, APHP Paris France |
| authorships[16].author.id | https://openalex.org/A5082590273 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Carole Barin |
| authorships[16].countries | FR |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210095477 |
| authorships[16].affiliations[0].raw_affiliation_string | Laboratoire de cytogénétique hématologique, Service de génétique CHU Bretonneau Tours France |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[16].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[16].institutions[0].id | https://openalex.org/I4210095477 |
| authorships[16].institutions[0].ror | https://ror.org/00jpq0w62 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210095477 |
| authorships[16].institutions[0].country_code | FR |
| authorships[16].institutions[0].display_name | Centre Hospitalier Universitaire de Tours |
| authorships[16].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[16].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[16].institutions[1].type | nonprofit |
| authorships[16].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[16].institutions[1].country_code | FR |
| authorships[16].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Carole Barin |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire de cytogénétique hématologique, Service de génétique CHU Bretonneau Tours France |
| authorships[17].author.id | https://openalex.org/A5027227964 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-1085-4267 |
| authorships[17].author.display_name | Virginie Éclache |
| authorships[17].countries | FR |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210138283 |
| authorships[17].affiliations[0].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[17].affiliations[1].institution_ids | https://openalex.org/I39804081, https://openalex.org/I4210121705 |
| authorships[17].affiliations[1].raw_affiliation_string | Hopital Pitié‐Salpétrière AP‐HP France |
| authorships[17].institutions[0].id | https://openalex.org/I4210138283 |
| authorships[17].institutions[0].ror | https://ror.org/04db0ec72 |
| authorships[17].institutions[0].type | nonprofit |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210138283 |
| authorships[17].institutions[0].country_code | FR |
| authorships[17].institutions[0].display_name | Groupe Francophone des Myélodysplasies |
| authorships[17].institutions[1].id | https://openalex.org/I4210121705 |
| authorships[17].institutions[1].ror | https://ror.org/02mh9a093 |
| authorships[17].institutions[1].type | healthcare |
| authorships[17].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[17].institutions[1].country_code | FR |
| authorships[17].institutions[1].display_name | Pitié-Salpêtrière Hospital |
| authorships[17].institutions[2].id | https://openalex.org/I39804081 |
| authorships[17].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[17].institutions[2].type | education |
| authorships[17].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[17].institutions[2].country_code | FR |
| authorships[17].institutions[2].display_name | Sorbonne Université |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Virginie Eclache |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Hopital Pitié‐Salpétrière AP‐HP France |
| authorships[18].author.id | https://openalex.org/A5034054835 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-7943-8800 |
| authorships[18].author.display_name | Olivier Mansier |
| authorships[18].countries | FR |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I4387154723 |
| authorships[18].affiliations[0].raw_affiliation_string | INSERM U1034, Biology of cardiovascular disease Pessac France |
| authorships[18].affiliations[1].institution_ids | https://openalex.org/I3018323443 |
| authorships[18].affiliations[1].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[18].institutions[0].id | https://openalex.org/I4387154723 |
| authorships[18].institutions[0].ror | https://ror.org/0463z7496 |
| authorships[18].institutions[0].type | facility |
| authorships[18].institutions[0].lineage | https://openalex.org/I15057530, https://openalex.org/I154526488, https://openalex.org/I4387154723 |
| authorships[18].institutions[0].country_code | |
| authorships[18].institutions[0].display_name | Biologie des maladies cardiovasculaires |
| authorships[18].institutions[1].id | https://openalex.org/I3018323443 |
| authorships[18].institutions[1].ror | https://ror.org/01hq89f96 |
| authorships[18].institutions[1].type | healthcare |
| authorships[18].institutions[1].lineage | https://openalex.org/I3018323443 |
| authorships[18].institutions[1].country_code | FR |
| authorships[18].institutions[1].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[18].institutions[2].id | https://openalex.org/I154526488 |
| authorships[18].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[18].institutions[2].type | government |
| authorships[18].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[18].institutions[2].country_code | FR |
| authorships[18].institutions[2].display_name | Inserm |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Olivier Mansier |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | INSERM U1034, Biology of cardiovascular disease Pessac France, Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[19].author.id | https://openalex.org/A5004118893 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Audrey Bidet |
| authorships[19].countries | FR |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I3018323443 |
| authorships[19].affiliations[0].raw_affiliation_string | Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| authorships[19].affiliations[1].institution_ids | https://openalex.org/I4210138283 |
| authorships[19].affiliations[1].raw_affiliation_string | Groupe Francophone de Cytogénétique Hématologique (GFCH) |
| authorships[19].institutions[0].id | https://openalex.org/I3018323443 |
| authorships[19].institutions[0].ror | https://ror.org/01hq89f96 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I3018323443 |
| authorships[19].institutions[0].country_code | FR |
| authorships[19].institutions[0].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[19].institutions[1].id | https://openalex.org/I4210138283 |
| authorships[19].institutions[1].ror | https://ror.org/04db0ec72 |
| authorships[19].institutions[1].type | nonprofit |
| authorships[19].institutions[1].lineage | https://openalex.org/I4210138283 |
| authorships[19].institutions[1].country_code | FR |
| authorships[19].institutions[1].display_name | Groupe Francophone des Myélodysplasies |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Audrey Bidet |
| authorships[19].is_corresponding | True |
| authorships[19].raw_affiliation_strings | Groupe Francophone de Cytogénétique Hématologique (GFCH), Laboratoire d'Hématologie Biologique CHU Bordeaux Bordeaux France |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://hal.science/hal-04022577 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10309 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Acute Myeloid Leukemia Research |
| related_works | https://openalex.org/W4376132749, https://openalex.org/W4211107528, https://openalex.org/W2418058659, https://openalex.org/W2150931085, https://openalex.org/W2411982442, https://openalex.org/W200867328, https://openalex.org/W2046562108, https://openalex.org/W2385379090, https://openalex.org/W2322089729, https://openalex.org/W4311497573 |
| cited_by_count | 8 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 5 |
| locations_count | 4 |
| best_oa_location.id | pmh:oai:HAL:hal-04022577v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402512 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| best_oa_location.source.host_organization | https://openalex.org/I1294671590 |
| best_oa_location.source.host_organization_name | Centre National de la Recherche Scientifique |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1294671590 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Journal articles |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Genes, Chromosomes & Cancer, 2023, 62 (3), pp.139-151. ⟨10.1002/gcc.23107⟩ |
| best_oa_location.landing_page_url | https://hal.science/hal-04022577 |
| primary_location.id | doi:10.1002/gcc.23107 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S200862508 |
| primary_location.source.issn | 1045-2257, 1098-2264 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1045-2257 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Genes Chromosomes and Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Genes, Chromosomes and Cancer |
| primary_location.landing_page_url | https://doi.org/10.1002/gcc.23107 |
| publication_date | 2022-11-22 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2806970239, https://openalex.org/W4252225072, https://openalex.org/W1969676572, https://openalex.org/W2107398329, https://openalex.org/W4283271244, https://openalex.org/W4283716970, https://openalex.org/W2339658711, https://openalex.org/W1987487063, https://openalex.org/W2460571264, https://openalex.org/W1997757445, https://openalex.org/W2329836851, https://openalex.org/W2169476614, https://openalex.org/W2517784383, https://openalex.org/W2064224156, https://openalex.org/W2051403172, https://openalex.org/W2142939874, https://openalex.org/W2073301684, https://openalex.org/W4285493817, https://openalex.org/W2981923411, https://openalex.org/W3010784781, https://openalex.org/W3208199354, https://openalex.org/W1993236149, https://openalex.org/W2561161989, https://openalex.org/W2551607099, https://openalex.org/W2830196912, https://openalex.org/W2277853540, https://openalex.org/W3182365126, https://openalex.org/W2135898863, https://openalex.org/W3001237554, https://openalex.org/W2065890382, https://openalex.org/W3206778834, https://openalex.org/W3134752999, https://openalex.org/W3179808235, https://openalex.org/W3097549907, https://openalex.org/W3119440663, https://openalex.org/W1605230984 |
| referenced_works_count | 36 |
| abstract_inverted_index.a | 28, 40, 74, 106, 109 |
| abstract_inverted_index.34 | 91 |
| abstract_inverted_index.In | 80 |
| abstract_inverted_index.It | 18 |
| abstract_inverted_index.We | 113, 125 |
| abstract_inverted_index.an | 100 |
| abstract_inverted_index.as | 203 |
| abstract_inverted_index.be | 25, 63, 201 |
| abstract_inverted_index.by | 9, 27 |
| abstract_inverted_index.if | 71 |
| abstract_inverted_index.in | 45, 65, 77 |
| abstract_inverted_index.is | 19, 56 |
| abstract_inverted_index.it | 55 |
| abstract_inverted_index.of | 12, 34, 48, 50, 68, 90, 102, 108, 121, 157, 168, 179 |
| abstract_inverted_index.or | 70, 97 |
| abstract_inverted_index.to | 53, 181 |
| abstract_inverted_index.we | 83, 195 |
| abstract_inverted_index.CA. | 152 |
| abstract_inverted_index.MDS | 23, 134, 165, 184, 192, 213 |
| abstract_inverted_index.The | 153 |
| abstract_inverted_index.and | 14, 88, 105, 136, 155, 164, 177, 190, 205 |
| abstract_inverted_index.are | 4, 130 |
| abstract_inverted_index.can | 24, 200 |
| abstract_inverted_index.for | 212 |
| abstract_inverted_index.not | 57 |
| abstract_inverted_index.now | 20 |
| abstract_inverted_index.one | 96, 150 |
| abstract_inverted_index.the | 10, 46, 66, 85, 169, 172, 208 |
| abstract_inverted_index.who | 93 |
| abstract_inverted_index.(HR) | 183 |
| abstract_inverted_index.CCUS | 69, 78 |
| abstract_inverted_index.Most | 145 |
| abstract_inverted_index.more | 98, 139 |
| abstract_inverted_index.only | 149 |
| abstract_inverted_index.risk | 178 |
| abstract_inverted_index.show | 126 |
| abstract_inverted_index.than | 133 |
| abstract_inverted_index.that | 22, 127, 137, 197 |
| abstract_inverted_index.they | 72, 138 |
| abstract_inverted_index.this | 81, 115 |
| abstract_inverted_index.type | 156 |
| abstract_inverted_index.were | 159, 185 |
| abstract_inverted_index.with | 43, 95, 119, 142 |
| abstract_inverted_index.(CA). | 112 |
| abstract_inverted_index.(MDS) | 3 |
| abstract_inverted_index.Thus, | 194 |
| abstract_inverted_index.carry | 73 |
| abstract_inverted_index.clear | 58 |
| abstract_inverted_index.date, | 54 |
| abstract_inverted_index.known | 21 |
| abstract_inverted_index.named | 114 |
| abstract_inverted_index.older | 132 |
| abstract_inverted_index.these | 128 |
| abstract_inverted_index.which | 38 |
| abstract_inverted_index.CACtUS | 146, 162, 188, 198 |
| abstract_inverted_index.called | 31 |
| abstract_inverted_index.cells. | 17 |
| abstract_inverted_index.clonal | 32 |
| abstract_inverted_index.entity | 116 |
| abstract_inverted_index.impact | 76 |
| abstract_inverted_index.marker | 42 |
| abstract_inverted_index.number | 154 |
| abstract_inverted_index.should | 62, 206 |
| abstract_inverted_index.study, | 82 |
| abstract_inverted_index.(CCUS), | 37 |
| abstract_inverted_index.absence | 47, 101 |
| abstract_inverted_index.anemia. | 144 |
| abstract_inverted_index.between | 161, 187 |
| abstract_inverted_index.defined | 8 |
| abstract_inverted_index.myeloid | 16 |
| abstract_inverted_index.overall | 175 |
| abstract_inverted_index.receive | 207 |
| abstract_inverted_index.regimen | 210 |
| abstract_inverted_index.similar | 186 |
| abstract_inverted_index.suggest | 196 |
| abstract_inverted_index.unknown | 35 |
| abstract_inverted_index.whether | 59 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 52 |
| abstract_inverted_index.analyzed | 84 |
| abstract_inverted_index.criteria | 49 |
| abstract_inverted_index.features | 87 |
| abstract_inverted_index.outcomes | 89 |
| abstract_inverted_index.patients | 92, 129, 135, 147, 163, 189, 199 |
| abstract_inverted_index.preceded | 26 |
| abstract_inverted_index.presence | 11, 107 |
| abstract_inverted_index.slightly | 131 |
| abstract_inverted_index.(CACtUS). | 124 |
| abstract_inverted_index.HR‐CCUS | 204 |
| abstract_inverted_index.clonality | 41 |
| abstract_inverted_index.condition | 30 |
| abstract_inverted_index.cytopenia | 33, 44, 120 |
| abstract_inverted_index.exhibited | 148 |
| abstract_inverted_index.mutations | 158 |
| abstract_inverted_index.patients. | 79, 166, 193, 214 |
| abstract_inverted_index.presented | 94, 141 |
| abstract_inverted_index.survival, | 176 |
| abstract_inverted_index.syndromes | 2 |
| abstract_inverted_index.Regardless | 167 |
| abstract_inverted_index.associates | 39 |
| abstract_inverted_index.comparable | 160 |
| abstract_inverted_index.considered | 64, 202 |
| abstract_inverted_index.definition | 67 |
| abstract_inverted_index.dysmorphic | 15 |
| abstract_inverted_index.dysplasia, | 104 |
| abstract_inverted_index.dysplasia. | 51 |
| abstract_inverted_index.frequently | 140 |
| abstract_inverted_index.low‐risk | 191 |
| abstract_inverted_index.normocytic | 143 |
| abstract_inverted_index.prognostic | 75 |
| abstract_inverted_index.unbalanced | 151 |
| abstract_inverted_index.abnormality | 111, 118 |
| abstract_inverted_index.chromosomal | 60, 110, 117 |
| abstract_inverted_index.classically | 7 |
| abstract_inverted_index.cytogenetic | 170 |
| abstract_inverted_index.cytopenias, | 99 |
| abstract_inverted_index.follow‐up | 209 |
| abstract_inverted_index.high‐risk | 182 |
| abstract_inverted_index.progression | 180 |
| abstract_inverted_index.recommended | 211 |
| abstract_inverted_index.significant | 103 |
| abstract_inverted_index.abnormality, | 171 |
| abstract_inverted_index.cytopenia(s) | 13 |
| abstract_inverted_index.malignancies | 6 |
| abstract_inverted_index.significance | 36, 123 |
| abstract_inverted_index.undetermined | 122 |
| abstract_inverted_index.abnormalities | 61 |
| abstract_inverted_index.hematological | 5 |
| abstract_inverted_index.Myelodysplastic | 1 |
| abstract_inverted_index.pre‐malignant | 29 |
| abstract_inverted_index.characteristics, | 174 |
| abstract_inverted_index.clinicobiological | 173 |
| abstract_inverted_index.clinico‐biological | 86 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5004118893 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 20 |
| corresponding_institution_ids | https://openalex.org/I3018323443, https://openalex.org/I4210138283 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7699999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.83079586 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |